Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000896264-25-000205
Filing Date
2025-08-05
Accepted
2025-08-05 16:50:15
Documents
66
Period of Report
2025-06-28

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20250628.htm   iXBRL 10-Q 1115074
2 EX-31.1 usna-20250628xex311.htm EX-31.1 9855
3 EX-31.2 usna-20250628xex312.htm EX-31.2 9724
4 EX-32.1 usna-20250628xex321.htm EX-32.1 3440
5 EX-32.2 usna-20250628xex322.htm EX-32.2 3830
  Complete submission text file 0000896264-25-000205.txt   5738088

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20250628.xsd EX-101.SCH 31017
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT usna-20250628_cal.xml EX-101.CAL 66538
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT usna-20250628_def.xml EX-101.DEF 128292
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20250628_lab.xml EX-101.LAB 482514
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20250628_pre.xml EX-101.PRE 329212
68 EXTRACTED XBRL INSTANCE DOCUMENT usna-20250628_htm.xml XML 834713
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 251185758
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)